
---
title: '中信证券：动保估值底部，关注非瘟疫苗催化'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=3352'
author: 证券时报网
comments: false
date: Tue, 11 Jan 2022 08:54:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=3352'
---

<div>   
<p>证券时报网讯，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600030" code="600030">中信证券</a>指出，目前动保企业估值已跌至历史低位。短期来看，行业受益于集中度提升、2022年养殖景气边际好转以及潜在非瘟新品的催化。长期来看，行业持续受益养殖规模化程度、养宠渗透率的提升，产品力、销售力领先的公司将致胜。重点推荐<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS603566" code="603566">普莱柯</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600201" code="600201">生物股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS688526" code="688526">科前生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002100" code="002100">天康生物</a>等。</p>

                  
</div>
            